ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

Chinese startup develops PCR testing equipment for household use

Product gives accurate COVID-19 test results without special training

Ustar has developed PCR testing equipment for household use. (Phot courtesy of the company)

BEIJING -- Ustar, a Chinese point of care (POC) startup that designs molecular diagnostic systems, has raised about 300 million yuan ($2.6 million) in a Series E+ funding round.

The investment was led by CPE Yuanfeng. Current Ustar shareholder Oriental Fortune Capital also made an additional investment.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more